Open AccessCharacteristics of patients with Alzheimer’s disease who switch to rivastigmine transdermal patches in routine clinical practice
Author(s) -
F. J. Arranz,
Secundino LópezPousa
Publication year - 2013
Publication title -
patient preference and adherence
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.885
H-Index - 48
ISSN - 1177-889X
DOI - 10.2147/ppa.s38719
Subject(s) - rivastigmine , galantamine , donepezil , medicine , tolerability , odds ratio , concomitant , dementia , observational study , logistic regression , retrospective cohort study , pharmacology , disease , adverse effect
The aim of this study was to assess the sociodemographic and clinical characteristics of patients with Alzheimer's disease who switched from any oral cholinesterase inhibitor to rivastigmine patches.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom